Serum creatinine concentration, the classical biomarker of chronic kidney disease (CKD) in
cats, has important limitations that decrease its value as a biomarker of early CKD. Recently …

Current conventional tests of kidney damage and function in blood (serum creatinine and
urea nitrogen) and urine (urine protein creatinine ratio and urine specific gravity) are widely …

A host of novel renal biomarkers have been developed over the past few decades which
have enhanced monitoring of renal disease and drug-induced kidney injury in both …

Objectives To expand the number of conditions and interventions explored for their
associations with thrombosis in the veterinary literature and to provide the basis for …

Background Glomerular filtration rate (GFR) is the gold standard in assessing renal function
but is impractical. Serum creatinine (sCr) has limited sensitivity in identifying early chronic …

Background Urinary protein: creatinine ratio (UPC) results affect the diagnosis, prognosis,
and therapy of chronic kidney disease in cats. Objectives To investigate the interlaboratory …

Background Symmetric dimethylarginine (SDMA) has been increasingly used as a marker of
early chronic kidney disease (CKD) in cats, but little is known about the influence of …

Diabetes mellitus (DM) is the first cause of end stage chronic kidney disease (CKD). Animal
models of the disease can shed light on the pathogenesis of the diabetic nephropathy (DN) …

Background Serum cystatin C (sC ysC) and urinary cystatin C (uC ysC) are potential
biomarkers for early detection of chronic kidney disease (CKD) in cats. An in‐depth clinical …

Background Diabetes mellitus is the main cause of chronic kidney disease (CKD) in
humans. The relationship between the 2 diseases in cats is unclear. Objective To assess the …